Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 2.7.11.* (protein-serine/threonine kinase) inhibitor
go back to main search page
Accession:CHEBI:76812 term browser browse the term
Definition:An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any protein-serine/threonine kinase (EC 2.7.11.*).
Synonyms:related_synonym: EC 2.7.11.* inhibitor;   EC 2.7.11.* inhibitors;   protein-serine/threonine kinase (EC 2.7.11.*) inhibitors;   protein-serine/threonine kinase inhibitor;   protein-serine/threonine kinase inhibitors


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19770
    role 19718
      biological role 19717
        inhibitor 18219
          enzyme inhibitor 18144
            EC 2.* (transferase) inhibitor 13802
              EC 2.7.* (P-containing group transferase) inhibitor 13488
                EC 2.7.11.* (protein-serine/threonine kinase) inhibitor 8159
                  EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor + 1153
                  EC 2.7.11.10 (IkappaB kinase) inhibitor + 209
                  EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor + 188
                  EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor + 27
                  EC 2.7.11.13 (protein kinase C) inhibitor + 3425
                  EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor + 49
                  EC 2.7.11.18 (myosin-light-chain kinase) inhibitor + 183
                  EC 2.7.11.20 (elongation factor 2 kinase) inhibitor + 0
                  EC 2.7.11.21 (polo kinase) inhibitor + 0
                  EC 2.7.11.22 (cyclin-dependent kinase) inhibitor + 268
                  EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor + 680
                  EC 2.7.11.26 (tau-protein kinase) inhibitor + 98
                  EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor + 22
                  EC 2.7.11.31 \{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase\} inhibitor + 5646
Path 2
Term Annotations click to browse term
  CHEBI ontology 19770
    role 19718
      biological role 19717
        inhibitor 18219
          enzyme inhibitor 18144
            EC 2.* (transferase) inhibitor 13802
              EC 2.7.* (P-containing group transferase) inhibitor 13488
                protein kinase inhibitor 13019
                  EC 2.7.11.* (protein-serine/threonine kinase) inhibitor 8159
                    EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor + 1153
                    EC 2.7.11.10 (IkappaB kinase) inhibitor + 209
                    EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor + 188
                    EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor + 27
                    EC 2.7.11.13 (protein kinase C) inhibitor + 3425
                    EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor + 49
                    EC 2.7.11.18 (myosin-light-chain kinase) inhibitor + 183
                    EC 2.7.11.20 (elongation factor 2 kinase) inhibitor + 0
                    EC 2.7.11.21 (polo kinase) inhibitor + 0
                    EC 2.7.11.22 (cyclin-dependent kinase) inhibitor + 268
                    EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor + 680
                    EC 2.7.11.26 (tau-protein kinase) inhibitor + 98
                    EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor + 22
                    EC 2.7.11.31 \{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase\} inhibitor + 5646
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.